Read More Pharma Industry News Bristol-Myers Squibb partners with Compugen to trial COM701 and Opdivo combination for advanced solid tumors Bristol-Myers Squibb’s (BMS) latest clinical partnership with Israeli company Compugen is set to explore the efficacy of combining… bypharmanewsdailyOctober 13, 2018
